Campbell & Co Investment Adviser’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.35M	Buy	+33,519	New	+$1.25M	0.08%	404
2024 Q4	–	Sell	-9,292	Closed	-$430K	–	1100
2024 Q3	$430K	Buy	+9,292	New	+$330K	0.03%	771
2024 Q1	–	Sell	-32,578	Closed	-$1.06M	–	1137
2023 Q4	$1.06M	Buy	32,578 +22,548	+225%	+$619K	0.1%	363
2023 Q3	$273K	Sell	10,030 -13,320	-57%	-$386K	0.03%	747
2023 Q2	$520K	Buy	23,350 +3,910	+20%	+$90K	0.09%	421
2023 Q1	$421K	Sell	19,440 -44,688	-70%	-$980K	0.08%	489
2022 Q4	$1.3M	Buy	64,128 +27,211	+74%	+$682K	0.31%	48
2022 Q3	$947K	Buy	36,917 +17,875	+94%	+$478K	0.22%	139
2022 Q2	$453K	Sell	19,042 -34,458	-64%	-$751K	0.12%	310
2022 Q1	$1.21M	Buy	+53,500	New	+$1.14M	0.32%	52
2021 Q4	–	Sell	-16,200	Closed	-$319K	–	640
2021 Q3	$319K	Buy	16,200 +1,550	+11%	+$32.4K	0.1%	358
2021 Q2	$322K	Buy	14,650 +2,950	+25%	+$65.6K	0.13%	299
2021 Q1	$278K	Buy	+11,700	New	+$312K	0.17%	251
2020 Q4	–	Sell	-29,487	Closed	-$513K	–	440
2020 Q3	$513K	Buy	+29,487	New	+$470K	0.38%	68
2020 Q1	–	Sell	-64,508	Closed	-$781K	–	127
2019 Q4	$781K	Buy	+64,508	New	+$898K	0.24%	97
2017 Q4	–	Sell	-23,300	Closed	-$450K	–	411
2017 Q3	$450K	Buy	23,300 +8,770	+60%	+$131K	0.36%	76
2017 Q2	$171K	Sell	14,530 -83	-0.6%	-$902	0.16%	283
2017 Q1	$160K	Sell	14,613 -1,498	-9%	-$13.2K	0.41%	119
2016 Q4	$117K	Sell	16,111 -5,335	-25%	-$41.8K	0.36%	116
2016 Q3	$139K	Buy	21,446 +5,652	+36%	+$32.9K	0.37%	118
2016 Q2	$86K	Buy	+15,794	New	+$82.2K	0.43%	78